Skip to main content
Monday, November 16, 2026Nov 16

Report: Drugmakers, distributors under federal opioid probe

This June 17, 2019, file photo shows 5-mg pills of Oxycodone. At least a half-dozen companies that make or distribute prescription opioid painkillers are facing a federal criminal investigation of their roles in a nationwide addiction and overdose crisis. The Wall Street Journal first reported the investigation Tuesday, Nov. 26, 2019, citing unnamed sources familiar with the probe. (AP Photo/Keith Srakocic, File)
This June 17, 2019, file photo shows 5-mg pills of Oxycodone. At least a half-dozen companies that make or distribute prescription opioid painkillers are facing a federal criminal investigation of their roles in a nationwide addiction and overdose crisis. The Wall Street Journal first reported the investigation Tuesday, Nov. 26, 2019, citing unnamed sources familiar with the probe. (AP Photo/Keith Srakocic, File)

At least a half-dozen companies that make or distribute prescription opioid painkillers are facing a federal criminal investigation of their roles in a nationwide addiction and overdose crisis.

The Wall Street Journal first reported the investigation Tuesday, citing unnamed sources familiar with the probe.

Many activists have called for drug companies to not only be sued but to face criminal charges. An investigation is a step in that direction, though it is not clear when or whether any criminal charges might be filed.

The newspaper said drugmakers Amneal Pharmaceuticals, Johnson & Johnson, Mallinckrodt and Teva Pharmaceutical Industries had received grand-jury subpoenas from the U.S. Attorney’s Office in Brooklyn, along with drug distributors AmerisourceBergen and McKesson.

Most of the companies have disclosed federal subpoenas related to opioids in filings this year with the U.S. Securities and Exchange Commission.